Molecular pathology and prostate cancer therapeutics: from biology to bedside-Reference-Cited by-同舟云学术

Molecular pathology and prostate cancer therapeutics: from biology to bedside

Published:2013-12-10 Issue:2 Volume:232 Page:178-184
ISSN:0022-3417
Container-title:The Journal of Pathology
language:en
Short-container-title:J. Pathol.

Author:

Rodrigues Daniel Nava¹,Butler Lisa M²,Estelles David Lorente¹,de Bono Johann S¹

Affiliation:

1. Prostate Cancer Targeted Therapy Group and Drug Development Unit; Royal Marsden NHS Foundation Trust and Institute of Cancer Research; Sutton Surrey UK

2. Dame Roma Mitchell Cancer Research Laboratories and Adelaide Prostate Cancer Research Centre, School of Medicine, Freemason's Foundation Centre for Men's Health; University of Adelaide and Hanson Institute; Adelaide South Australia

Publisher

Wiley

Subject

Pathology and Forensic Medicine

Reference67 articles.

1. Global cancer statistics;Jemal;CA Cancer J Clin,2011

2. Bostwick DG Cheng L. Urologic Surgical Pathology 2nd edn Elsevier

3. The genomic and transcriptomic architecture of 2000 breast tumours reveals novel subgroups;Curtis;Nature,2012

4. Molecular signature and pathway analysis of human primary squamous and adenocarcinoma lung cancers;Daraselia;Am J Cancer Res,2012

5. RET fusions define a unique molecular and clinicopathologic subtype of non-small-cell lung cancer;Wang;J Clin Oncol,2012

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of N⁶‑methyladenosine in the pathogenesis, diagnosis and treatment of prostate cancer (Review);Oncology Reports;2024-05-13

2. Activation of Dendritic Cells Isolated from the Blood of Patients with Prostate Cancer by Ex Vivo Fluid Shear Stress Stimulation;Current Protocols;2023-12

3. Combined Effects of Sodium Valproate and Lithium Chloride on Inducing Apoptosis and Inhibiting Invasion of PC3 Cells;MIDDLE EAST J CANCER;2023

4. Large-Scale Proteomics Data Reveal Integrated Prognosis-Related Protein Signatures and Role of SMAD4 and RAD50 in Prognosis and Immune Infiltrations of Prostate Cancer Microenvironment;Phenomics;2022-09-27

5. The Value of Multimodality PET/CT Imaging in Detecting Prostate Cancer Biochemical Recurrence;Frontiers in Endocrinology;2022-05-27